WiseGuyReports.Com Publish a New Market Research Report On – “Nanomedicine 2017 Global Market Expected to Grow at CAGR 17.1% and Forecast to 2023”.
Overview: Nanomedicine is an offshoot of nanotechnology, and refers to highly-specific medical intervention at the molecular scale for curing diseases or repairing damaged tissues. Nanomedicine uses nano-sized tools for the diagnosis, prevention and treatment of disease, and to gain increased understanding of the complex underlying pathophysiology of the disease. It involves three nanotechnology areas of diagnosis, imaging agents, and drug delivery with nanoparticles in the 1–1,000 nm range, biochips, and polymer therapeutics.
The majority of nanomedicines used now allow oral drug delivery and its demand is increasing significantly. Although these nanovectors are designed to translocate across the gastrointestinal tract, lung, and blood–brain barrier, the amount of drug transferred to the organ is lower than 1%; therefore improvements are challenging. Nanomedicines are designed to maximize the benefit/risk ratio, and their toxicity must be evaluated not only by sufficiently long term in vitro and in vivo studies, but also pass multiple clinical studies.
The major drivers of the nanomedicine market include its application in various therapeutic areas, increasing R&D studies about nanorobots in this segment, and significant investments in clinical trials by the government as well as private sector. The Oncology segment is the major therapeutic area for nanomedicine application, which comprised more than 35% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the nanomedicine market in the future.
For more information or any query mail at email@example.com
Market Analysis: The “Global Nanomedicine Market” is estimated to witness a CAGR of 17.1% during the forecast period 2017–2023. The nanomedicine market is analyzed based on two segments – therapeutic applications and regions.
Regional Analysis: The regions covered in the report are the Americas, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the nanomedicine market growth followed by Europe. The Asia Pacific and ROW are set to be the emerging regions. Japan is set to be the most attractive destination and in Africa, the popularity and the usage of various nano-drugs are expected to increase in the coming years. The major countries covered in this report are the US, Germany, Japan, and Others.
Therapeutic Application Analysis: Nanomedicines are used as fluorescent markers for diagnostic and screening purposes. Moreover, nanomedicines are introducing new therapeutic opportunities for a large number of agents that cannot be used effectively as conventional oral formulations due to poor bioavailability. The therapeutic areas for nanomedicine application are Oncology, Cardiovascular, Neurology, Anti-inflammatory, Anti-infectives, and various other areas. Globally, the industry players are focusing significantly on R&D to gain approval for various clinical trials for future nano-drugs to be commercially available in the market. The FDA should be relatively prepared for some of the earliest and most basic applications of nanomedicine in areas such as gene therapy and tissue engineering. The more advanced applications of nanomedicine will pose unique challenges in terms of classification and maintenance of scientific expertise.
Key Players: Merck & Co. Inc., Hoffmann-La Roche Ltd., Gilead Sciences Inc., Novartis AG, Amgen Inc., Pfizer Inc., Eli Lilly and Company, Sanofi, Nanobiotix SA, UCB SA and other predominate & niche players.
Competitive Analysis: At present, the nanomedicine market is at a nascent stage – but, a lot of new players are entering the market as it holds huge business opportunities. Especially, big players along with the collaboration with other SMBs for clinical trials of nanoparticles and compounds are coming with new commercial targeted drugs in the market and they are expecting a double-digit growth in the upcoming years. Significant investments in R&D in this market are expected to increase and collaborations, merger & acquisition activities are expected to continue.
Benefits: The report provides complete details about the usage and adoption rate of nanomedicines in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives towards the nanomedicine adoption in the upcoming years along with the details of commercial drugs available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Table Of Contents – Major Key Points
1 Industry Outlook 10
1.1 Industry Overview 10
1.2 Industry Trends 11
1.3 PEST Analysis 12
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 13
2.3 Research Methodology 14
2.4 Report Assumptions 14
3 Market Snapshot 16
3.1 Total Addressable Market (TAM) 16
3.2 Segmented Addressable Market (SAM) 16
3.3 Related Markets 17
3.3.1 mHealth Market 17
3.3.2 Healthcare Analytics Market 18
4 Market Outlook 18
4.1 Overview 18
4.2 Regulatory Bodies and Standards 19
4.3 Government Spending and Initiatives 19
4.4 Porter 5 (Five) Forces 21
5 Market Characteristics 22
5.1 Evolution 22
5.2 Ecosystem 25
5.2.1 Regulatory Process 25
5.2.2 Clinical Trials 25
5.2.3 Pricing and Reimbursement 26
5.3 Market Segmentation 28
5.4 Market Dynamics 28
5.4.1 Drivers 29
220.127.116.11 Emergence of nanorobotics 29
18.104.22.168 Applications and advantages of nanomedicine in various healthcare segments 29
22.214.171.124 Reasonable investments in R&D 30
126.96.36.199 Increased support from governments 30
5.4.2 Restraints 31
188.8.131.52 Long approval process and stringent regulations 31
184.108.40.206 Problems regarding nanoscale manufacturing 31
220.127.116.11 Risks related to nanomedicines 31
18.104.22.168 Undefined regulatory standards 31
5.4.3 Opportunities 32
22.214.171.124 Aging population with chronic care needs 32
126.96.36.199 Population and income growth in emerging countries 32
5.4.4 DRO – Impact Analysis 33
6 Trends, Roadmap and Projects 34
6.1 Market Trends and Impact 34
6.2 Technology Roadmap 35
7 Types: Market Size and Analysis 36
7.1 Overview 36
7.2 Global Nanomedicine Market in Oncology Segment 37
7.3 Global Nanomedicine Market in Cardiovascular Segment 38
7.4 Global Nanomedicine Market in Neurology Segment 39
7.5 Global Nanomedicine Market in Anti-inflammatory Segment 39
7.6 Global Nanomedicine Market in Anti-infective Segment 40
7.7 Global Nanomedicine Market in Other Therapeutic Areas 41
8 Trending Nanomedicines 42
8.1 Overview 42
8.2 Abraxane 43
8.3 Alimta 43
8.4 Eligard 44
8.5 Copaxone 44
8.6 Rapamune 44
8.7 Neulasta 45
8.8 Cimzia 45
8.9 AmBisome 46
8.10 Mircera 46
8.11 Pegasys 46
8.12 Emend 47
8.13 Renagel 47
8.14 Ritalin 47
For more information or any query mail at firstname.lastname@example.org
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.